Helicobacter Pylori Testing Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	301 Pages	Future Market Insights	July, 2022	FMARI18389939

Best Price Guarantee
Price	from $5,000
Length	301 Pages
Publisher	Future Market Insights
Published Date	July, 2022
SKU	FMARI18389939

Helicobacter Pylori Testing Market: Global Industry Analysis 2017-2021 and Opportunity Assessment 2022-2032

A recent market study published by FMI on Helicobacter Pylori Testing offers a global industry analysis for 2017-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Test Type:

With Endoscopy
Histology
Rapid Urease Testing
PCR (Polymerase Chain Reaction)
Culture Testing
Without Endoscopy
Stool/Faecal Antigen Test
Urea Breath Test
H. Pylori Antibody Testing

By End User:

Hospitals
Private Labs
Public Health Labs
Physician Offices

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Report Chapters

Executive Summary

The executive summary of the Helicobacter Pylori Testing Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Helicobacter Pylori Testing.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Helicobacter Pylori Testing Market in this chapter, which will help to understand basic information about Helicobacter Pylori Testing. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Helicobacter Pylori Testing Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Nature processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Helicobacter Pylori Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

The chapter include historical market value (US$ XX Billion) analysis (2017-2021) and current and future market value (US$ 173.1 Million Million) and volume (7.4%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Helicobacter Pylori Testing Market - Pricing Analysis

Based on By Nature, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Test Type

Based on By Test Type, Helicobacter Pylori Testing Market is segmented into With Endoscopy, (Histology, Rapid Urease Testing, PCR (Polymerase Chain Reaction), Culture Testing), Without Endoscopy, (Stool/Faecal Antigen Test, Urea Breath Test, H. Pylori Antibody Testing). This section also offers market attractiveness analysis based on By Test Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Test Type.

Chapter 06 - Global Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User

Based on By End User, Helicobacter Pylori Testing Market is segmented into Hospitals, Private Labs, Public Health Labs, Physician Offices. This section also offers market attractiveness analysis based on By End User. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End User.

Chapter 07 - Global Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

Based on By Region, Helicobacter Pylori Testing Market is segmented into North America,Latin America,Europe,East Asia,South Asia & Pacific,Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 08 - North America Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Helicobacter Pylori Testing in the North American Region, along with a country-wise assessment that includes the US and Canada. Readers can also find Regional trends, regulations, and market growth based on different segment and countries in the North America Region.

Chapter 09 - Latin America Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Helicobacter Pylori Testing in the Latin America Region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Helicobacter Pylori Testing Market in the Latin America Region.

Chapter 10 - Europe Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Helicobacter Pylori Testing in the European Region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Helicobacter Pylori Testing Market in the Regional market.

Chapter 11 - East Asia Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Helicobacter Pylori Testing in the East Asia Region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Helicobacter Pylori Testing Market in the Regional market.

Chapter 12 - South Asia Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Helicobacter Pylori Testing in the South Asia Region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Helicobacter Pylori Testing Market in the Regional market.

Chapter 13 - Middle East and Africa Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Helicobacter Pylori Testing in the MEA Region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Helicobacter Pylori Testing Market in the Regional market.

Chapter 14 - Key Countries Helicobacter Pylori Testing Market Analysis 2017-2021 and Forecast 2022-2032

This chapter offers insights into how the Helicobacter Pylori Testing Market is expected to grow in major countries globally.

Chapter 15 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 16 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Nature portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Abbott Laboratories, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd., Sekisui Diagnostics, LLC.

Chapter 17 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Helicobacter Pylori Testing report.

Chapter 18 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Helicobacter Pylori Testing Market.

1. Executive Summary | Helicobacter Pylori Testing Market: 1.1. Global Market Outlook; 1.2. Demand-side Trends; 1.3. Supply-side Trends; 1.4. Technology Roadmap Analysis; 1.5. Analysis and Recommendations
2. Market Overview: 2.1. Market Coverage / Taxonomy; 2.2. Market Definition / Scope / Limitations
3. Market Background: 3.1. Market Dynamics; 3.1.1. Drivers; 3.1.2. Restraints; 3.1.3. Opportunity; 3.1.4. Trends; 3.2. Scenario Forecast; 3.2.1. Demand in Optimistic Scenario; 3.2.2. Demand in Likely Scenario; 3.2.3. Demand in Conservative Scenario; 3.3. Opportunity Map Analysis; 3.4. Investment Feasibility Matrix; 3.5. PESTLE and Porter’s Analysis; 3.6. Regulatory Landscape; 3.6.1. By Key Regions; 3.6.2. By Key Countries; 3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032: 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021; 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032; 4.2.1. Y-o-Y Growth Trend Analysis; 4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Test Type: 5.1. Introduction / Key Findings; 5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2017 to 2021; 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2022 to 2032; 5.3.1. With Endoscopy; 5.3.2. Histology; 5.3.3. Rapid Urease Testing; 5.3.4. Culture; 5.3.5. PCR (Polymerase Chain Reaction); 5.3.6. Without Endoscopy; 5.3.7. Stool/Faecal Antigen Test; 5.3.8. Urea Breath Test; 5.3.9. H. Pylori Antibody Testing; 5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017 to 2021; 5.5. Absolute $ Opportunity Analysis By Test Type, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User: 6.1. Introduction / Key Findings; 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021; 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032; 6.3.1. Hospitals; 6.3.2. Private Labs; 6.3.3. Public Health Labs; 6.3.4. Physician Offices; 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021; 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region: 7.1. Introduction; 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021; 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032; 7.3.1. North America; 7.3.2. Latin America; 7.3.3. Europe; 7.3.4. Asia Pacific; 7.3.5. Middle East and Africa; 7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country: 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021; 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032; 8.2.1. By Country; 8.2.1.1. United States of America; 8.2.1.2. Canada; 8.2.2. By Test Type; 8.2.3. By End User; 8.3. Market Attractiveness Analysis; 8.3.1. By Country; 8.3.2. By Test Type; 8.3.3. By End User; 8.4. Key Takeaways
9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country: 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021; 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032; 9.2.1. By Country; 9.2.1.1. Brazil; 9.2.1.2. Mexico; 9.2.1.3. Rest of Latin America; 9.2.2. By Test Type; 9.2.3. By End User; 9.3. Market Attractiveness Analysis; 9.3.1. By Country; 9.3.2. By Test Type; 9.3.3. By End User; 9.4. Key Takeaways
10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country: 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021; 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032; 10.2.1. By Country; 10.2.1.1. Germany; 10.2.1.2. United Kingdom; 10.2.1.3. France; 10.2.1.4. Spain; 10.2.1.5. Italy; 10.2.1.6. Rest of Europe; 10.2.2. By Test Type; 10.2.3. By End User; 10.3. Market Attractiveness Analysis; 10.3.1. By Country; 10.3.2. By Test Type; 10.3.3. By End User; 10.4. Key Takeaways
11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country: 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021; 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032; 11.2.1. By Country; 11.2.1.1. China; 11.2.1.2. Japan; 11.2.1.3. South Korea; 11.2.1.4. India; 11.2.1.5. Malaysia; 11.2.1.6. Singapore; 11.2.1.7. Australia; 11.2.1.8. New Zealand; 11.2.1.9. Rest of Asia-Pacific; 11.2.2. By Test Type; 11.2.3. By End User; 11.3. Market Attractiveness Analysis; 11.3.1. By Country; 11.3.2. By Test Type; 11.3.3. By End User; 11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country: 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021; 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032; 12.2.1. By Country; 12.2.1.1. GCC Countries; 12.2.1.2. South Africa; 12.2.1.3. Israel; 12.2.1.4. Rest of Middle East and Africa; 12.2.2. By Test Type; 12.2.3. By End User; 12.3. Market Attractiveness Analysis; 12.3.1. By Country; 12.3.2. By Test Type; 12.3.3. By End User; 12.4. Key Takeaways
13. Key Countries Market Analysis: 13.1. United States of America; 13.1.1. Pricing Analysis; 13.1.2. Market Share Analysis, 2021; 13.1.2.1. By Test Type; 13.1.2.2. By End User; 13.2. Canada; 13.2.1. Pricing Analysis; 13.2.2. Market Share Analysis, 2021; 13.2.2.1. By Test Type; 13.2.2.2. By End User; 13.3. Brazil; 13.3.1. Pricing Analysis; 13.3.2. Market Share Analysis, 2021; 13.3.2.1. By Test Type; 13.3.2.2. By End User; 13.4. Mexico; 13.4.1. Pricing Analysis; 13.4.2. Market Share Analysis, 2021; 13.4.2.1. By Test Type; 13.4.2.2. By End User; 13.5. Germany; 13.5.1. Pricing Analysis; 13.5.2. Market Share Analysis, 2021; 13.5.2.1. By Test Type; 13.5.2.2. By End User; 13.6. United Kingdom; 13.6.1. Pricing Analysis; 13.6.2. Market Share Analysis, 2021; 13.6.2.1. By Test Type; 13.6.2.2. By End User; 13.7. France; 13.7.1. Pricing Analysis; 13.7.2. Market Share Analysis, 2021; 13.7.2.1. By Test Type; 13.7.2.2. By End User; 13.8. Spain; 13.8.1. Pricing Analysis; 13.8.2. Market Share Analysis, 2021; 13.8.2.1. By Test Type; 13.8.2.2. By End User; 13.9. Italy; 13.9.1. Pricing Analysis; 13.9.2. Market Share Analysis, 2021; 13.9.2.1. By Test Type; 13.9.2.2. By End User; 13.10. China; 13.10.1. Pricing Analysis; 13.10.2. Market Share Analysis, 2021; 13.10.2.1. By Test Type; 13.10.2.2. By End User; 13.11. Japan; 13.11.1. Pricing Analysis; 13.11.2. Market Share Analysis, 2021; 13.11.2.1. By Test Type; 13.11.2.2. By End User; 13.12. South Korea; 13.12.1. Pricing Analysis; 13.12.2. Market Share Analysis, 2021; 13.12.2.1. By Test Type; 13.12.2.2. By End User; 13.13. Malaysia; 13.13.1. Pricing Analysis; 13.13.2. Market Share Analysis, 2021; 13.13.2.1. By Test Type; 13.13.2.2. By End User; 13.14. Singapore; 13.14.1. Pricing Analysis; 13.14.2. Market Share Analysis, 2021; 13.14.2.1. By Test Type; 13.14.2.2. By End User; 13.15. Australia; 13.15.1. Pricing Analysis; 13.15.2. Market Share Analysis, 2021; 13.15.2.1. By Test Type; 13.15.2.2. By End User; 13.16. New Zealand; 13.16.1. Pricing Analysis; 13.16.2. Market Share Analysis, 2021; 13.16.2.1. By Test Type; 13.16.2.2. By End User; 13.17. GCC Countries; 13.17.1. Pricing Analysis; 13.17.2. Market Share Analysis, 2021; 13.17.2.1. By Test Type; 13.17.2.2. By End User; 13.18. South Africa; 13.18.1. Pricing Analysis; 13.18.2. Market Share Analysis, 2021; 13.18.2.1. By Test Type; 13.18.2.2. By End User; 13.19. Israel; 13.19.1. Pricing Analysis; 13.19.2. Market Share Analysis, 2021; 13.19.2.1. By Test Type; 13.19.2.2. By End User
14. Market Structure Analysis: 14.1. Competition Dashboard; 14.2. Competition Benchmarking; 14.3. Market Share Analysis of Top Players; 14.3.1. By Regional; 14.3.2. By Test Type; 14.3.3. By End User
15. Competition Analysis: 15.1. Competition Deep Dive; 15.1.1. Abbott; 15.1.1.1. Overview; 15.1.1.2. Product Portfolio; 15.1.1.3. Profitability by Market Segments; 15.1.1.4. Sales Footprint; 15.1.1.5. Strategy Overview; 15.1.1.5.1. Marketing Strategy; 15.1.2. ADI/American Diagnostica; 15.1.2.1. Overview; 15.1.2.2. Product Portfolio; 15.1.2.3. Profitability by Market Segments; 15.1.2.4. Sales Footprint; 15.1.2.5. Strategy Overview; 15.1.2.5.1. Marketing Strategy; 15.1.3. Agilent Technologies; 15.1.3.1. Overview; 15.1.3.2. Product Portfolio; 15.1.3.3. Profitability by Market Segments; 15.1.3.4. Sales Footprint; 15.1.3.5. Strategy Overview; 15.1.3.5.1. Marketing Strategy; 15.1.4. Bio-Rad Laboratories Inc.; 15.1.4.1. Overview; 15.1.4.2. Product Portfolio; 15.1.4.3. Profitability by Market Segments; 15.1.4.4. Sales Footprint; 15.1.4.5. Strategy Overview; 15.1.4.5.1. Marketing Strategy; 15.1.5. Helena Laboratories; 15.1.5.1. Overview; 15.1.5.2. Product Portfolio; 15.1.5.3. Profitability by Market Segments; 15.1.5.4. Sales Footprint; 15.1.5.5. Strategy Overview; 15.1.5.5.1. Marketing Strategy; 15.1.6. Horiba; 15.1.6.1. Overview; 15.1.6.2. Product Portfolio; 15.1.6.3. Profitability by Market Segments; 15.1.6.4. Sales Footprint; 15.1.6.5. Strategy Overview; 15.1.6.5.1. Marketing Strategy; 15.1.7. Takara Bio; 15.1.7.1. Overview; 15.1.7.2. Product Portfolio; 15.1.7.3. Profitability by Market Segments; 15.1.7.4. Sales Footprint; 15.1.7.5. Strategy Overview; 15.1.7.5.1. Marketing Strategy; 15.1.8. EKF Diagnostics; 15.1.8.1. Overview; 15.1.8.2. Product Portfolio; 15.1.8.3. Profitability by Market Segments; 15.1.8.4. Sales Footprint; 15.1.8.5. Strategy Overview; 15.1.8.5.1. Marketing Strategy; 15.1.9. Exalenz Bioscience Ltd.; 15.1.9.1. Overview; 15.1.9.2. Product Portfolio; 15.1.9.3. Profitability by Market Segments; 15.1.9.4. Sales Footprint; 15.1.9.5. Strategy Overview; 15.1.9.5.1. Marketing Strategy; 15.1.10. Sekisui Diagnostics; 15.1.10.1. Overview; 15.1.10.2. Product Portfolio; 15.1.10.3. Profitability by Market Segments; 15.1.10.4. Sales Footprint; 15.1.10.5. Strategy Overview; 15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology